# Regeneron Pharmaceuticals, Inc.: contracts, H-1B (2026)

Registers read on November 19, 2026.

Regeneron Pharmaceuticals, Inc. (New York) appears in 3 public registers SpecStream reads: 6 federal contract awards, 623 certified H-1B and PERM cases and 5 SEC annual and quarterly reports; the newest record is dated November 3, 2026, and the registers were read on November 19, 2026.

SpecStream is the live web data engine for teams and agents. This page joins the public registers SpecStream already reads for one company.

- Registers: 3
- Newest record: November 3, 2026
- State: New York

## Federal contract awards (USAspending)

6 federal contract awards, newest November 3, 2026.

- UEI: N3F9MH7E6HD6
- Business size: Other Than Small Business
- Obligated: $-53.7 million

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [Department of Veterans Affairs](https://specstream.ai/data/federal-awards/recipient/regeneron-pharmaceuticals-inc-n3f9mh7e6hd6) | September 30, 2021 | BPA, NAICS 325412; $0 obligated | [usaspending.gov](https://www.usaspending.gov/award/CONT_IDV_36E79721A0023_3600/) |
| [Department of Veterans Affairs](https://specstream.ai/data/federal-awards/recipient/regeneron-pharmaceuticals-inc-n3f9mh7e6hd6) | June 1, 2021 | FSS, NAICS 325412; $0 obligated | [usaspending.gov](https://www.usaspending.gov/award/CONT_IDV_36F79721D0169_3600/) |
| [Department of Health and Human Services](https://specstream.ai/data/federal-awards/recipient/regeneron-pharmaceuticals-inc-n3f9mh7e6hd6) | September 30, 2017 | Definitive Contract, NAICS 541711; $280.5 million obligated | [usaspending.gov](https://www.usaspending.gov/award/CONT_AWD_HHSO100201700016C_7505_-NONE-_-NONE-/) |
| [Department of Health and Human Services](https://specstream.ai/data/federal-awards/recipient/regeneron-pharmaceuticals-inc-n3f9mh7e6hd6) | September 21, 2017 | Definitive Contract, NAICS 541711; $-332.5 million obligated | [usaspending.gov](https://www.usaspending.gov/award/CONT_AWD_HHSO100201700020C_7505_-NONE-_-NONE-/) |
| [Department of Health and Human Services](https://specstream.ai/data/federal-awards/recipient/regeneron-pharmaceuticals-inc-n3f9mh7e6hd6) | August 9, 2016 | Definitive Contract, NAICS 541711; $-337.5 thousand obligated | [usaspending.gov](https://www.usaspending.gov/award/CONT_AWD_HHSO100201600023C_7505_-NONE-_-NONE-/) |
| [Department of Health and Human Services](https://specstream.ai/data/federal-awards/recipient/regeneron-pharmaceuticals-inc-n3f9mh7e6hd6) | September 2, 2015 | IDC, NAICS 541711; $-1.4 million obligated | [usaspending.gov](https://www.usaspending.gov/award/CONT_IDV_HHSO100201500013C_7505/) |

- [REGENERON PHARMACEUTICALS INC](https://specstream.ai/data/federal-awards/recipient/regeneron-pharmaceuticals-inc-n3f9mh7e6hd6)

## H-1B and PERM certifications (Department of Labor)

623 certified H-1B and PERM cases, newest September 14, 2026.

- EIN: 13-3444607

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [Sr Scientist](https://specstream.ai/data/hiring/employer/regeneron-pharmaceuticals-inc-133444607) | September 14, 2026 | H-1B, 11 cases, $143.9 thousand offered | [dol.gov](https://www.dol.gov/media/LCA_Disclosure_Data_FY2026_Q4.xlsx) |
| [Sr Scientist-Research & Tech Development](https://specstream.ai/data/hiring/employer/regeneron-pharmaceuticals-inc-133444607) | September 1, 2026 | H-1B, 2 cases, $154.9 thousand offered | [dol.gov](https://www.dol.gov/media/LCA_Disclosure_Data_FY2026_Q4.xlsx) |
| [Associate Director Data Management](https://specstream.ai/data/hiring/employer/regeneron-pharmaceuticals-inc-133444607) | August 19, 2026 | H-1B, 2 cases, $222.5 thousand offered | [dol.gov](https://www.dol.gov/media/LCA_Disclosure_Data_FY2026_Q4.xlsx) |
| [Assoc Dir Service Delivery Management](https://specstream.ai/data/hiring/employer/regeneron-pharmaceuticals-inc-133444607) | August 18, 2026 | H-1B, 2 cases, $222 thousand offered | [dol.gov](https://www.dol.gov/media/LCA_Disclosure_Data_FY2026_Q4.xlsx) |
| [Director Product Management](https://specstream.ai/data/hiring/employer/regeneron-pharmaceuticals-inc-133444607) | August 18, 2026 | H-1B, 2 cases, $251.4 thousand offered | [dol.gov](https://www.dol.gov/media/LCA_Disclosure_Data_FY2026_Q4.xlsx) |
| [Principal Statistical Programmer](https://specstream.ai/data/hiring/employer/regeneron-pharmaceuticals-inc-133444607) | August 10, 2026 | H-1B, 5 cases, $152.5 thousand offered | [dol.gov](https://www.dol.gov/media/LCA_Disclosure_Data_FY2026_Q4.xlsx) |
| [Senior Associate Scientist](https://specstream.ai/data/hiring/employer/regeneron-pharmaceuticals-inc-133444607) | August 5, 2026 | H-1B, 4 cases, $103.8 thousand offered | [dol.gov](https://www.dol.gov/media/LCA_Disclosure_Data_FY2026_Q4.xlsx) |
| [Principal Scientist](https://specstream.ai/data/hiring/employer/regeneron-pharmaceuticals-inc-133444607) | July 29, 2026 | H-1B, 18 cases, $159.8 thousand offered | [dol.gov](https://www.dol.gov/media/LCA_Disclosure_Data_FY2026_Q4.xlsx) |
| [Staff IOPS Data Engineer](https://specstream.ai/data/hiring/employer/regeneron-pharmaceuticals-inc-133444607) | July 24, 2026 | H-1B, 2 cases, $175 thousand offered | [dol.gov](https://www.dol.gov/media/LCA_Disclosure_Data_FY2026_Q4.xlsx) |
| [Senior Manager Statistical Programming](https://specstream.ai/data/hiring/employer/regeneron-pharmaceuticals-inc-133444607) | July 23, 2026 | H-1B, 2 cases, $199 thousand offered | [dol.gov](https://www.dol.gov/media/LCA_Disclosure_Data_FY2026_Q4.xlsx) |

- [Regeneron Pharmaceuticals, Inc.](https://specstream.ai/data/hiring/employer/regeneron-pharmaceuticals-inc-133444607)

## Public company financials (SEC)

5 SEC annual and quarterly reports, newest February 4, 2026.

- SEC central index key (CIK): 872589
- Industry: SIC 2834, Pharmaceutical preparations
- Filer category: Large accelerated filer

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [10-K filed February 4, 2026](https://specstream.ai/data/public-companies/company/872589-regeneron-pharmaceuticals-inc) | February 4, 2026 | Revenue $14.3 billion | [sec.gov](https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/0000872589-26-000008-index.htm) |

- [Regeneron Pharmaceuticals, Inc.](https://specstream.ai/data/public-companies/company/872589-regeneron-pharmaceuticals-inc)

## How these records were matched

Records are joined when they carry the same SEC CIK, EIN or UEI, or when their legal names match word for word, legal form aside, at an address in the same state (New York), and no register gives a second identifier, a second headquarters or a second filer of that name. Each record links to its own page and to the agency that published it.

Source: the registers named in each section. Public records of US federal and state agencies.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in New York, New York

- [Pharmaceutical companies in New York, New York](https://specstream.ai/data/businesses/pharmaceutical-companies/new-york-new-york-united-states)
- [Medical research institutes in New York, New York](https://specstream.ai/data/businesses/medical-research-institutes/new-york-new-york-united-states)
- [Coffee shops in New York, New York](https://specstream.ai/data/businesses/coffee-shops/new-york-new-york-united-states)
- [Research institutes in New York, New York](https://specstream.ai/data/businesses/research-institutes/new-york-new-york-united-states)
- [Gastropubs in New York, New York](https://specstream.ai/data/businesses/gastropubs/new-york-new-york-united-states)
- [Ambulance services in New York, New York](https://specstream.ai/data/businesses/ambulance-services/new-york-new-york-united-states)
